推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733，021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

CURRENT CANCER DRUG TARGETS 期刊收藏夹

2026年3月最新《新锐期刊分区表》数据已更新，欢迎查询使用。如果您对期刊系统有任何需求或者问题，欢迎点击此处反馈给我们。

期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   新锐期刊分区表:   是否OA期刊:   结果排序:
  体验更多LetPub AI科研工具 >>
智能期刊推荐助手

推荐偏好:

  
学术改写降重工具

 
同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看：


CURRENT CANCER DRUG TARGETS期刊基本信息Hello，您是该期刊的第48900位访客


基本信息 登录收藏
期刊名字CURRENT CANCER DRUG TARGETSCURRENT CANCER DRUG TARGETS

CURR CANCER DRUG TAR
（此期刊被最新的JCR期刊SCIE收录）

LetPub评分
6.5
54人评分
我要评分

声誉
7.6

影响力
5.2

速度
8.9

期刊ISSN1568-0096
安装APP，查看期刊最新消息
iOS版下载安装安卓版下载安装
E-ISSN1873-5576
2024-2025最新影响因子
（数据来源于搜索引擎）		3.5 点击查看影响因子趋势图
实时影响因子 截止2026年5月06日：2.46
2024-2025自引率2.9%点击查看自引率趋势图
五年影响因子2.9
JCI期刊引文指标 0.53
h-index 85
CiteScore
（ 2025年最新版）
CiteScoreSJRSNIPCiteScore排名
4.100.7220.443
学科分区排名百分位
大类：Medicine
小类：Oncology		Q2198 / 415
大类：Medicine
小类：Pharmacology		Q3175 / 321
大类：Medicine
小类：Drug Discovery		Q391 / 156
大类：Medicine
小类：Cancer Research		Q3147 / 233

期刊简介
Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes and genes.

Current Cancer Drug Targets publishes original research articles, letters, reviews / mini-reviews, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cancer.

As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.
期刊官方网站http://benthamscience.com/journal/index.php?journalID=ccdt
期刊投稿格式模板
VIP专享
Word版格式模板  
此模板由LetPub整理，仅供参考。开通VIP可免费下载，并享1w+期刊模板资源。
 
期刊投稿网址http://bsp-cms.eurekaselect.com/index.php/CCDT
该期刊中国学者近期发文 - NewDDX18 as a Prognostic Biomarker Associated with Pan-Cancer Immune Infiltration and Drug Sensitivity
Author: Jia, Yanan; Wang, Ruolin; Li, Haiyang; Li, Xianliang; He, Qiang
Journal: CURRENT CANCER DRUG TARGETS. 2026; Vol. , Issue , pp. -. DOI: 10.2174/0115680096398222251129152123

The FHL Protein Family in Cancer: Roles, Dysregulation, and Therapeutic Implications
Author: Zhang, Yuanzhu; Tian, Zhenghui; Fan, Qiming; Zhang, Kexin; Sun, Xiaodong; Kan, Chengxia; Han, Fang
Journal: CURRENT CANCER DRUG TARGETS. 2026; Vol. , Issue , pp. -. DOI: 10.2174/0115680096412852251126052148

Arctigenin Suppresses Melanoma via Mitophagy Activation In vitro and Enhances Dacarbazine Sensitivity In vivo
Author: Jiang, Ling; Lu, Yang; Zhao, Hongyan; He, Weiyang
Journal: CURRENT CANCER DRUG TARGETS. 2025; Vol. , Issue , pp. -. DOI: 10.2174/0115680096373796250414062644

Exosome-mediated Induction of Apoptosis in Cisplatin-treated Gastric Cancer Cells as a Strategy to Mitigate Side Effects
Author: Zhu, Jiaqi; Wang, Hui; Liu, Yijie; Li, Wen; Cao, Li; Wang, Wenjing; Li, Suoni; Shang, Jin; Qin, Yannan; Huang, Chen; Guo, Bo
Journal: CURRENT CANCER DRUG TARGETS. 2025; Vol. , Issue , pp. -. DOI: 10.2174/0115680096369817250407164352

期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足CURRENT CANCER DRUG TARGETS的语言要求，还能让CURRENT CANCER DRUG TARGETS编辑和审稿人得到更好的审稿体验，让稿件最大限度地被CURRENT CANCER DRUG TARGETS编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。
提交文稿
是否OA开放访问No
通讯方式BENTHAM SCIENCE PUBL LTD, EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, SHARJAH, U ARAB EMIRATES, 1200 BR
出版商Bentham Science Publishers B.V.
涉及的研究方向医学-肿瘤学
出版国家或地区NETHERLANDS
出版语言English
出版周期Bimonthly
出版年份2001
年文章数 156点击查看年文章数趋势图
Gold OA文章占比5.10%
研究类文章占比：
文章 ÷（文章 + 综述）		67.31%
WOS期刊JCR分区
（ 2024-2025年最新版）		WOS分区等级：2区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科：ONCOLOGYSCIEQ2106/328
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科：ONCOLOGYSCIEQ3202/328
期刊分区表预警名单 2026年03月发布的新锐学术版：不在预警名单中

2025年03月发布的2025版：不在预警名单中

2024年02月发布的2024版：不在预警名单中

2023年01月发布的2023版：不在预警名单中

2021年12月发布的2021版：不在预警名单中

2020年12月发布的2020版：不在预警名单中
《新锐期刊分区表》
（ 2026年3月发布） 		点击查看期刊分区表趋势图
大类学科小类学科Top期刊综述期刊
医学 4区3区1区
ONCOLOGY
肿瘤学		1区4区4区
否N/A
期刊分区表
（ 2025年3月升级版）
大类学科小类学科Top期刊综述期刊
医学 2区4区2区
ONCOLOGY
肿瘤学		2区1区4区
否否
期刊分区表
（ 2023年12月旧的升级版）
大类学科小类学科Top期刊综述期刊
医学 4区4区3区
ONCOLOGY
肿瘤学		2区3区4区
否否
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1568-0096%5BISSN%5D
平均审稿速度网友分享经验：
平均1月
平均录用比例网友分享经验：
约50%
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在CURRENT CANCER DRUG TARGETS顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 。
提交文稿
期刊常用信息链接
同领域相关期刊 CURRENT CANCER DRUG TARGETS期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 CURRENT CANCER DRUG TARGETS期刊分区表趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
CURRENT CANCER DRUG TARGETS上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 期刊分区表趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 期刊分区表相关期刊
  • 同类著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS1441154.20
    Nature Reviews Clinical Oncology127114.50
    NATURE REVIEWS CANCER396103.80
    ANNALS OF ONCOLOGY21070.40
    CANCER CELL29557.70
    JOURNAL OF CLINICAL ONCOLOGY49438.90
    LANCET ONCOLOGY27450.80
    CANCER RESEARCH41117.80
    SEMINARS IN CANCER BIOLOGY13435.00
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH6720.20
    期刊分区表同大类学科的热搜期刊 浏览次数
    MEDICINE869298
    JOURNAL OF ETHNOPHARMACOLOGY778900
    Frontiers in Immunology708112
    BIOMEDICINE & PHARMACOTHERAPY702241
    BIOMATERIALS696483
    Frontiers in Pharmacology684560
    PHYTOMEDICINE611795
    Frontiers in Oncology599314
    IEEE Journal of Biomedical and Health Informatics566516
    Biomedical Signal Processing and Control563824
  •  

    CURRENT CANCER DRUG TARGETS CURRENT CANCER DRUG TARGETS
    我来预测明年：
    稳步上升 表现平稳 逐渐下降　 刷新
  •  

    		  
  •  

    		  
  •  

    		  
  • 中国学者近期发表的论文
    1.DDX18 as a Prognostic Biomarker Associated with Pan-Cancer Immune Infiltration and Drug Sensitivity

    Author: Jia, Yanan; Wang, Ruolin; Li, Haiyang; Li, Xianliang; He, Qiang
    Journal: CURRENT CANCER DRUG TARGETS. 2026; Vol. , Issue , pp. -. DOI: 10.2174/0115680096398222251129152123        DOI
    2.The FHL Protein Family in Cancer: Roles, Dysregulation, and Therapeutic Implications

    Author: Zhang, Yuanzhu; Tian, Zhenghui; Fan, Qiming; Zhang, Kexin; Sun, Xiaodong; Kan, Chengxia; Han, Fang
    Journal: CURRENT CANCER DRUG TARGETS. 2026; Vol. , Issue , pp. -. DOI: 10.2174/0115680096412852251126052148        PubMed      DOI
    3.Arctigenin Suppresses Melanoma via Mitophagy Activation In vitro and Enhances Dacarbazine Sensitivity In vivo

    Author: Jiang, Ling; Lu, Yang; Zhao, Hongyan; He, Weiyang
    Journal: CURRENT CANCER DRUG TARGETS. 2025; Vol. , Issue , pp. -. DOI: 10.2174/0115680096373796250414062644        PubMed      DOI
    4.Exosome-mediated Induction of Apoptosis in Cisplatin-treated Gastric Cancer Cells as a Strategy to Mitigate Side Effects

    Author: Zhu, Jiaqi; Wang, Hui; Liu, Yijie; Li, Wen; Cao, Li; Wang, Wenjing; Li, Suoni; Shang, Jin; Qin, Yannan; Huang, Chen; Guo, Bo
    Journal: CURRENT CANCER DRUG TARGETS. 2025; Vol. , Issue , pp. -. DOI: 10.2174/0115680096369817250407164352        PubMed      DOI
    5.CREC Family Genes as Biomarkers and Therapeutic Targets in Lung Adenocarcinoma: In Vitro and In Silico Insights

    Author: Jiang, Yimin; Zhu, Guangfu; Cheng, Xueqin; Mo, Xinyue; Chen, Yi; Xu, Fengqi; Wang, Meifang; Tang, Yijun
    Journal: CURRENT CANCER DRUG TARGETS. 2025; Vol. , Issue , pp. -. DOI: 10.2174/0115680096363759250401045735        PubMed      DOI
    6.Trimethylamine N-oxide Impairs Oocyte Maturation and Embryogenesis via NF-κB/NLRP3 Pathway Modulation

    Author: He, Fengping; Zhang, Yongmei; Guo, Yanle; Yan, Tizhen; Lou, Jiwu
    Journal: CURRENT CANCER DRUG TARGETS. 2025; Vol. , Issue , pp. -. DOI: 10.2174/0115680096364675250419135908        PubMed      DOI
    7.Research Progress of M6A Methylation Modification in Immunotherapy of Colorectal Cancer

    Author: Zheng, Jingfan; Chen, Yuyu; Peng, Xintong; Zheng, Wei; Zhang, Yu; Hei, Fengrong; Lu, Zhong
    Journal: CURRENT CANCER DRUG TARGETS. 2025; Vol. , Issue , pp. -. DOI: 10.2174/0115680096332984250221071109        PubMed      DOI
    8.Competing Risk Analysis for Diabetes Mellitus Mortality in Bladder Cancer Patients: A Population-based Study

    Author: Wang, Shunde; Zheng, Baishu; Yang, Junjie; Zhang, Junyong
    Journal: CURRENT CANCER DRUG TARGETS. 2025; Vol. , Issue , pp. -. DOI: 10.2174/0115680096356675250217074915        PubMed      DOI
    9.LncRNA DERCNC in Hepatocellular Carcinoma with Cirrhosis Aggravates Tumor Proliferation by Targeting SOX9

    Author: Wang, Yun-Bing; Salameen, Haitham; Hu, Yi-Yu; Zhou, Shi-Ji; Gong, Jun-Hua
    Journal: CURRENT CANCER DRUG TARGETS. 2025; Vol. 25, Issue 6, pp. 665-679. DOI: 10.2174/0115680096310229240626102449        PubMed      DOI
    10.Low Expression MCEMP1 Promotes Lung Adenocarcinoma Progression and its Clinical Value (vol 25, pg 281, 2025)

    Author: Ling, Liqun; Hu, Tianqi; Zhou, Chenkang; Chen, Shuhui; Chou, Lunan; Chen, Yuxin; Hu, Zhaoting; Huang, Kate; Chen, Jie; Wang, Yumin; Wang, Junjun
    Journal: CURRENT CANCER DRUG TARGETS. 2025; Vol. 25, Issue 6, pp. 680-680. DOI: 10.2174/1568009625999250210092856        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS1441154.20
    NATURE REVIEWS DRUG DISCOVERY289181.80
    Kidney International Supplements2446.20
    LANCET70087.60
    Nature Reviews Clinical Oncology127114.50
    NEW ENGLAND JOURNAL OF MEDICINE93396.40
    NATURE REVIEWS CANCER396103.80
    World Psychiatry6174.00
    World Psychiatry7074.00
    ANNALS OF ONCOLOGY21070.40
    同分区等级的其他期刊名称 h-index CiteScore
    AI Open032.80
    Qualitative Psychology016.00
    Foundations and Trends in Information Retrieval2520.30
    COMMUNICATIONS OF THE ACM18914.30
    Business & Information Systems Engineering018.60
    Business & Information Systems Engineering018.60
    Advanced Sensor and Energy Materials01.00
    Battery Energy011.00
    Foundations and Trends in Computer Graphics and Vision016.90
    Ukrainian Journal of Physical Optics1412.30
以上SCI期刊相关数据和信息来源于网络，仅供参考。
投稿状态统计： 我要评分：
投稿前担心稿件结构或语言不够规范？试试稿件自查工具，一键检测 >>
与期刊沟通模版下载中心
VIP专享
掌握投稿全流程专业邮件模板，让您的学术沟通高效得体，显著提升论文发表效率！开通VIP可免费下载。
投稿信 (Cover Letter) 模板 回复信 (Response Letter) 模板 投稿状态查询 (Inquiry Letter) 模板
返修延期交稿 (Requesting Extension) 模板 变更作者信息申请 (Author Changes) 模板 拒稿后申诉信 (Appeal Letter) 模板
撤稿申请 (Withdrawal Request Letter) 模板 更正/勘误说明 (Corrigendum/Erratum) 模板 投稿前咨询信 (Pre-submission Inquiry) 模板
没有机构邮箱的说明 (Lack of institutional Email) 模板 更新中...

同领域作者分享投稿经验：共30条

    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2026 中国: LetPub上海    网站备案号：沪ICP备10217908号-1    沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）

    增值电信业务经营许可证：沪B2-20211595    网络文化经营许可证：沪网文[2023]2004-152号

    礼翰商务信息咨询（上海）有限公司      办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室